Revenue ₹3,603 Cr (+14.6% YoY)
0 met · 0 close · 2 missed across 2 tracked promises
View all executive profiles for Alkem Laboratories LimitedAlkem delivered a strong Q4 FY26 with revenue of ₹3,633 crore (+14.6% YoY) and EBITDA of ₹517.4 crore (+32.2% YoY), r...
0% promises delivered
Based on 2 tracked promises across 4 quarters
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
15 May 2026
Revenue ₹3,603 Cr (+14.6% YoY)
Alkem delivered a strong Q4 FY26 with revenue of ₹3,633 crore (+14.6% YoY) and EBITDA of ₹517.4 crore (+32.2% YoY), resulting in an EBITDA margin of 14.24% (+184 bps Y...
bullish
high
1 missed
Read full analysis →
Q3 FY26
13 Feb 2026
Revenue ₹3,737 Cr (+10.7% YoY)
Alkem delivered a stable Q3 with total revenue of ₹3,737 crore (+10.7% YoY) and EBITDA margin of 22.2%.
bullish
high
1 missed
Read full analysis →
Q2 FY26
06 Nov 2025
Revenue ₹4,001 Cr (+17.2% YoY)
Alkem delivered a strong Q2 FY26 with revenue of ₹4,010 crore (+17.2% YoY), driven by robust growth across India (+12.4%), US (+28%), and non-US markets (+32.4%).
bullish
high
Scorecard starts after historical backfill
Read full analysis →
Q1 FY26
06 Aug 2025
Revenue ₹3,371 Cr (+11.2% YoY)
Alkem Laboratories reported a strong Q1 FY26 with revenue of ₹3,371 crore (+11.2% YoY) and EBITDA of ₹739 crore (+21.4% YoY), driven by robust domestic growth (12% YoY...
bullish
high
Scorecard starts after historical backfill
Read full analysis →